Need professional-grade analysis? Visit stockanalysis.com
$4.76M
0.14
12
N/A
Price Chart
Risk-Adjusted Performance
Brain+ ApS (BRAINP) Price Performance
Brain+ ApS (BRAINP) trades on Nasdaq Copenhagen in DKK. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at DKK0.00.
Over the past year, BRAINP has traded between a low of DKK0.00 and a high of DKK0.02. The stock has lost 79.8% over this period. It is currently 81.7% below its 52-week high.
Brain+ ApS has a market capitalization of $4.76M, with a price-to-earnings ratio of 0.14.
About Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia care platform that offers high-quality and scalable cognitive stimulation therapy (CST). The company offers its products to healthcare providers, as well as patients and carers. Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.
Compare Brain+ ApS
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- Nasdaq Copenhagen
- Currency
- DKK
- Country
- Denmark
Financial Metrics
- Revenue (TTM)
- $5.80M
- EBITDA
- $-12,791,258
- Profit Margin
- -224.01%
- EPS (TTM)
- 0.03
- Book Value
- 0.05
Technical Indicators
- 52 Week High
- DKK 0.03
- 52 Week Low
- DKK 0.00
- 50 Day MA
- DKK 0.00
- 200 Day MA
- DKK 0.01
- Beta
- -0.34
Valuation
- Trailing P/E
- 0.14
- Forward P/E
- N/A
- Price/Sales
- 0.82
- Price/Book
- 0.33
- Enterprise Value
- $414,671